http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2352304-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cae5e9b15f1d1c920e9ab6f19b848e18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-49 |
| filingDate | 2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e897655412d1cee9329d5637f4f9b1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038f474fd4980e9e8b9da3fdc0645a13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d01932349eca41a1d6de95ebe911cba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934892757a2e769d24029fa14405acd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0953c54278084fa0ef027b997a9411f2 |
| publicationDate | 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2352304-C1 |
| titleOfInvention | Method of treatment of clottage of central vienna of retina |
| abstract | FIELD: medicine. n SUBSTANCE: invention concerns ophthalmology and is intended for treatment of patients with clottage of central vein of retina. Subtotal vitrectomy is spent. After excision of a vitreous body, the vitreous cavity is filled with air, entering a solution of the recombinant prourokinase on the retina in a projection of an optic disk in the amount of 0.5 ml 1500-2000 ME for 15-20 minutes then the rest of the preparation is washed away. After that the handpiece of the vitreotome is established over an optic disk and, in an aspiration regimen, at value of vacuum of 200-300 mm hg within 1 minute the gradient of pressure in the field of a trellised plate is alternately framed. Then again the vitreal cavity is filled with air and the recombinant prourokinase in the same volume 500-1000 ME is repeatedly entered, and the patient is located in a prone position for 2 hours. n EFFECT: method allows to provide fast penetration of clot-busting drug in a lumen of the central vein of retina and to carry out high-grade lysis of thrombus at level of a trellised plate with simultaneous partial destruction of thrombus and disturbance of its intimate communication with vascular wall. n 1 dwg, 1 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2593058-C1 |
| priorityDate | 2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.